These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 34655056)

  • 1. Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases.
    Parambi DGT; Alharbi KS; Kumar R; Harilal S; Batiha GE; Cruz-Martins N; Magdy O; Musa A; Panda DS; Mathew B
    Mol Neurobiol; 2022 Jan; 59(1):191-233. PubMed ID: 34655056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals.
    Singh M; Singh SP; Yadav D; Agarwal M; Agarwal S; Agarwal V; Swargiary G; Srivastava S; Tyagi S; Kaur R; Mani S
    Curr Gene Ther; 2021; 21(1):23-42. PubMed ID: 32811395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for neurodegenerative diseases.
    O'Connor DM; Boulis NM
    Trends Mol Med; 2015 Aug; 21(8):504-12. PubMed ID: 26122838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Gene Therapy Approaches for Targeting Neurodegenerative Disorders: Focusing on Delivering Neurotrophic Genes.
    Kumari S; Kamiya A; Karnik SS; Rohilla S; Dubey SK; Taliyan R
    Mol Neurobiol; 2024 Jun; ():. PubMed ID: 38856793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems.
    Bangde P; Atale S; Dey A; Pandit A; Dandekar P; Jain R
    Curr Gene Ther; 2017; 17(2):170-183. PubMed ID: 28494742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Role of Gene Therapy for Neurological Disorders.
    Puranik N; Yadav D; Chauhan PS; Kwak M; Jin JO
    Curr Gene Ther; 2021; 21(1):11-22. PubMed ID: 32940177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for neurodegenerative diseases based on lentiviral vectors.
    Nanou A; Azzouz M
    Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.
    Lim ST; Airavaara M; Harvey BK
    Pharmacol Res; 2010 Jan; 61(1):14-26. PubMed ID: 19840853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy.
    Cagin U
    Adv Exp Med Biol; 2021; 1286():213-223. PubMed ID: 33725356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and Advances in Gene Therapy Approaches for Neurodegenerative Disorders.
    Donde A; Wong PC; Chen LL
    Curr Gene Ther; 2017; 17(3):187-193. PubMed ID: 29034834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taking the knife to neurodegeneration: a review of surgical gene therapy delivery to the CNS.
    Perera A; Brock O; Ahmed A; Shaw C; Ashkan K
    Acta Neurochir (Wien); 2024 Mar; 166(1):136. PubMed ID: 38483631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth-factor gene therapy for neurodegenerative disorders.
    Tuszynski MH
    Lancet Neurol; 2002 May; 1(1):51-7. PubMed ID: 12849545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodegenerative Diseases: New Hopes and Perspectives.
    Bhat MA; Dhaneshwar S
    Curr Mol Med; 2024; 24(8):1004-1032. PubMed ID: 37691199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of lentiviral vectors for biology and gene therapy of neurological disorders.
    Lundberg C; Björklund T; Carlsson T; Jakobsson J; Hantraye P; Déglon N; Kirik D
    Curr Gene Ther; 2008 Dec; 8(6):461-73. PubMed ID: 19075629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
    Brennan FH; Lee JD; Ruitenberg MJ; Woodruff TM
    Semin Immunol; 2016 Jun; 28(3):292-308. PubMed ID: 27049459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell based-gene delivery approaches for the treatment of spinal cord injury and neurodegenerative disorders.
    Taha MF
    Curr Stem Cell Res Ther; 2010 Mar; 5(1):23-36. PubMed ID: 19951254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders.
    Paul S; Bravo Vázquez LA; Pérez Uribe S; Roxana Reyes-Pérez P; Sharma A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32679881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNAs as biomarkers of neurodegenerative disorders.
    Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
    Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future.
    Piguet F; Alves S; Cartier N
    Hum Gene Ther; 2017 Nov; 28(11):988-1003. PubMed ID: 29035118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic therapy for the nervous system.
    Bowers WJ; Breakefield XO; Sena-Esteves M
    Hum Mol Genet; 2011 Apr; 20(R1):R28-41. PubMed ID: 21429918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.